These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15707014)

  • 1. [Investigation of the hepatoprotector action of natural flavonoids].
    Dorkina EG
    Eksp Klin Farmakol; 2004; 67(6):41-4. PubMed ID: 15707014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hepatoprotective effect of thiophane in rats with experimental carbon tetrachloride-induced hepatitis].
    Smol'iakova VI; Plotnikov MB; Chernysheva GA; Ivanov IS; Prosenko AE; Kandalintseva NV
    Eksp Klin Farmakol; 2011; 74(8):37-40. PubMed ID: 22232913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of silymarin on experimental liver lesions.
    Barbarino F; Neumann E; Deaciuc I; Ghelberg NW; Suciu A; Cotuţiu C; Racoviţă L; Stroilă C; Nagy S; Părău N; Toader S; Brilinschi C
    Med Interne; 1981; 19(4):347-57. PubMed ID: 7336095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of antihepatotoxic tea on the course of drug-induced hepatitis].
    Ubeeva IP; Nikolaev SM; Sambueva ZG
    Antibiot Khimioter; 1989 Nov; 34(11):859-62. PubMed ID: 2633705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatoprotective activity of Leucas hirta against CCl4 induced hepatic damage in rats.
    Manjunatha BK; Vidya SM; Dhiman P; Pallavi R; Mankani KL
    Indian J Exp Biol; 2005 Aug; 43(8):722-7. PubMed ID: 16121714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of silymarin (Carsil) on the microsomal glycoprotein and protein biosynthesis in liver of rats with experimental galactosamine hepatitis.
    Tyutyulkova N; Gorantcheva U; Tuneva S; Chelibonova-Lorer H; Gavasova E; Zhivkov V
    Methods Find Exp Clin Pharmacol; 1983; 5(3):181-4. PubMed ID: 6888084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatoprotective effect of silymarin (carsil) on liver of D-galactosamine treated rats. Biochemical and morphological investigations.
    Tyutyulkova N; Tuneva S; Gorantcheva U; Tanev G; Zhivkov V; Chelibonova-Lorer H; Bozhkov S
    Methods Find Exp Clin Pharmacol; 1981; 3(2):71-7. PubMed ID: 7230979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of citrus flavonoids on the mutagenicity of heterocyclic amines and on cytochrome P450 1A2 activity.
    Bear WL; Teel RW
    Anticancer Res; 2000; 20(5B):3609-14. PubMed ID: 11131669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silymarin, a possible hepatoprotector in dairy cows: biochemical and histological observations.
    Tedesco D; Domeneghini C; Sciannimanico D; Tameni M; Steidler S; Galletti S
    J Vet Med A Physiol Pathol Clin Med; 2004 Mar; 51(2):85-9. PubMed ID: 15153078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The use of silymarin in patients with toxic and viral liver diseases].
    Matveev AV; Koniaeva EI
    Eksp Klin Gastroenterol; 2011; (5):84-90. PubMed ID: 21916240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The efficacy of vitogepat and sirepar in combination with karsil in chronic liver lesions].
    Skakun NP; Moseĭchuk IP; Gil' IaIa
    Eksp Klin Farmakol; 1992; 55(1):61-3. PubMed ID: 1305440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on uses and properties of citrus flavonoids: new findings in anticancer, cardiovascular, and anti-inflammatory activity.
    Benavente-García O; Castillo J
    J Agric Food Chem; 2008 Aug; 56(15):6185-205. PubMed ID: 18593176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Action of hepatoprotective agents in a tetracycline lesion of the liver].
    Porokhniak LA; Drogovoz SM; Rogozhin BA
    Antibiot Med Biotekhnol; 1987 Apr; 32(4):282-5. PubMed ID: 3631934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of naringin against drugs and chemical toxins induced hepatotoxicity: A review.
    Shirani K; Yousefsani BS; Shirani M; Karimi G
    Phytother Res; 2020 Aug; 34(8):1734-1744. PubMed ID: 32067280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of the plant hepatoprotector Galstena tuberculostatics-induced hepatic lesions: experimental and clinical study].
    Katikova OIu; Asanov BM; Vize-Khripunova MA; Burba EN; Ruzov VI
    Probl Tuberk; 2002; (4):32-6. PubMed ID: 12125250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms of citrus flavanones on hepatic gluconeogenesis.
    Constantin RP; Constantin RP; Bracht A; Yamamoto NS; Ishii-Iwamoto EL; Constantin J
    Fitoterapia; 2014 Jan; 92():148-62. PubMed ID: 24239748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatoprotectors prevent the toxic action of cyclophosphamide on the liver of rats with CCl4-induced hepatitis model].
    Rat'kin AV; Saratikov AS; Chuchalin VS; Burkova VN; Frolov VN
    Eksp Klin Farmakol; 2005; 68(2):47-50. PubMed ID: 15934368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatoprotector properties of polyphenolic complexes from wood and cell culture of Maackia amurensis].
    Saratikov AS; Chuchalin VS; Rat'kin AV; Rat'kin EV; Fedoreev SA; Bulgakov VP
    Eksp Klin Farmakol; 2005; 68(2):51-4. PubMed ID: 15934369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental studies on the effect of hepatoprotective compounds.
    Lapis K; Jeney A; Divald A; Vajta G; Zalatnai A; Schaff Z
    Tokai J Exp Clin Med; 1986; 11 Suppl():135-45. PubMed ID: 3330627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effectiveness of tocopherol and anti-hypoxic agents in liver damage caused by antitubercular agents].
    Skakun NP; Slivka IuI
    Probl Tuberk; 1991; (3):57-9. PubMed ID: 1871097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.